Stock Updates

Today’s Top Gainers in the Market BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) from Healthcare

Today’s top gainers include the company BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) which is in the industry Biotechnology, gaining 2.19% today. In the last week its performance is 0.99%, and 0.20% for the past quarter. Currently, BioMarin Pharmaceutical Inc., BMRN has a target price of 111.95, so today’s gain of 2.19% is a significant step towards its target price. The GAP today is therefore 1.23%.

BioMarin Pharmaceutical Inc. (NASDAQ:BMRN), has a market cap of 13925.18, and is based in USA. Insider ownership is at 0.60%, and institutional ownership is 100.00%.

At the current price of 89.03, it has a dividend yield of *TBA, and its target price is 111.95. This is with a profit margin of -20.50%, and total debt/equity of 0.29. BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) has a P/E of *TBA, as well as a forward P/E of *TBA.

With a current EPS of -1.18, and a forecasted EPS growth for next year at 54.00%,BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) has had a EPS growth for the past five years at -21.30%. For the next five years EPS growth is projected to be 25.00%.

Performance for the year is -39.54%. Since its IPO date on 7/26/1999, the total performance to date is -15.02%.

Volume today for BioMarin Pharmaceutical Inc. (NASDAQ:BMRN), is 1447011, while its average volume is 1609.32. Whilst the total gain today was 2.19%, it did have a day high of -4.31%.

Volatility for this week has been at 4.00%, and 4.54% for the month. The 52-week low for BioMarin Pharmaceutical Inc., BMRN has been 43.32%, while the 52-week-high has reached -41.33%.

Looking at its return of investments, which is -4.20%, and its return on assets is -5.20%. BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) has an operating margin of -13.60%. With a sales growth of 16.70% quarter over quarter. Bearing in mind that BioMarin Pharmaceutical Inc., BMRN is in the sector Healthcare, its long-term debt/equity is 0.29, and has a current ratio of 2.6 and 1.8 for quick ratio.

So what is the value of BioMarin Pharmaceutical Inc.? Well its PEG is *TBA, and the P/S is 15.07, along with a P/B of 6.28. Meanwhile it has a p/cash of 30.48.

Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.

About the author

Stephen Butters

Leave a Comment